Does Dr. ALTAGRACIA ALCANTARA GONZALEZ have financial conflicts of interest?

Dr. ALTAGRACIA ALCANTARA GONZALEZ (M.D.) has received a total of $428,546 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $8,411 in personal promotional payouts (consulting, meals, travel) and $420,135 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ALTAGRACIA ALCANTARA GONZALEZ?

According to CMS Open Payments data, Dr. ALTAGRACIA ALCANTARA GONZALEZ received funding from ELI LILLY EXPORT S.A. PUERTO RICO BRANCH ($299,993), ELI LILLY AND COMPANY ($121,752), and LILLY USA ($1,625).

Does Dr. ALTAGRACIA ALCANTARA GONZALEZ receive research grants or speaking fees?

Dr. ALTAGRACIA ALCANTARA GONZALEZ has received $8,411 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $420,135 in clinical research grants.

DR. ALTAGRACIA ALCANTARA GONZALEZ

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Endocrinology, Diabetes & Metabolism

Practice Location: BAYAMON, PR 00956

NPI Number: 1376505586

LIFETIME INDUSTRY VALUE

$428,546

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALCANTARA GONZALEZ is a verified Internal Medicine, Endocrinology, Diabetes & Metabolism practitioner based in BAYAMON, PR.

Between 2021 and 2025, Dr. ALCANTARA GONZALEZ had an overall industry promotional and research financial footprint of $428,546 as recorded in the federal CMS Open Payments database.

$8,411 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$420,135 was allocated to sponsored clinical trials and medical research activities.

Dr. ALCANTARA GONZALEZ's primary funding source is ELI LILLY EXPORT S.A. PUERTO RICO BRANCH, which accounts for $299,993 (representing 70% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ELI LILLY EXPORT S.A. PUERTO RICO BRANCH

Rank 1

$299,993

70%

ELI LILLY AND COMPANY

Rank 2

$121,752

28.4%

LILLY USA

Rank 3

$1,625

0.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.